Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03457116 · ClinicalTrials.gov registry record · Phase 4

Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty

A Phase 4 study of Opioid Use and Rhinoplasty, sponsored by NYU Langone Health.

Completed
Registry status
Phase 4
Development phase
70
Enrollment target
1
Study location

NCT03457116: Completed Phase 4 study of Opioid Use and Rhinoplasty, sponsored by NYU Langone Health.

NCT03457116 is a Phase 4 study of Opioid Use and Rhinoplasty that has completed, run by NYU Langone Health. The registered enrollment target is 70 participants, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03457116, a Phase 4 study of Opioid Use and Rhinoplasty, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
Phase 4
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the efficacy and safety of oral opiate pain medication vs non-steroidal ant inflammatory drugs (NSAIDs) in the treatment of postoperative rhinoplasty pain. This study will also evaluate potential contributing factors affecting the efficacy of these pain control methods. Patients will be randomized to receive either NSAIDs in the form of 400mg of Ibuprofen or Norco (hydrocodone 5mg- acetaminophen 325mg) to be used for post-operative pain. The study will then compare which is more effective in controlling post operative pain.

Primary Outcome

Pain scores are reported via Post-Operative Pain Management Survey. On a scale of 1-10, participants indicate how much pain they were in on their pain regiment. The higher the score, the worse the pain (1 = no pain, 10 = worst pain possible)

Interventions

  • DRUG NSAID
  • DRUG Norco

Study Locations (1)

New York

  • NYU Langone Medical Center - New York

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2018-01-30
Est. Completion 2020-11-02
Phase Phase 4
NYU Langone Health

1,164 total trials

What the finished NCT03457116 record still lists

NCT03457116 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which NSAID is the first listed.

NCT03457116 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03457116 about?

NCT03457116 is a clinical study titled "Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty". The purpose of this study is to compare the efficacy and safety of oral opiate pain medication vs non-steroidal ant inflammatory drugs (NSAIDs) in the treatment of postoperative rhinoplasty pain. This study will also evaluate potential contributing factors affecting the efficacy of these pain contro...

What is the current status of trial NCT03457116?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2018-01-30. Estimated completion is 2020-11-02.

What conditions does trial NCT03457116 study?

This clinical trial studies the following conditions: Opioid Use, Rhinoplasty, Non-steroidal Ant Inflammatory Drugs.

What interventions are being tested in trial NCT03457116?

The interventions under investigation include: NSAID (DRUG), Norco (DRUG).

Who is sponsoring clinical trial NCT03457116?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03457116 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03457116's enrollment target sits among peer trials

70 79th of 105 higher than 26 of 105 other Opioid Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03457116, the US trial registry maintained by the National Library of Medicine. NCT03457116 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.